Search
for
Sort by
Research 121–150 of 1000+
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- The Frontal Fibrosing Alopecia Syndrome: How a Single Word Name Change Might Change So Much
- Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
- Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- Tacrolimus in Dermatologic Disorders
- Aging in the Male Face: Intrinsic and Extrinsic Factors
- Menopause, skin and common dermatoses. Part 2: skin disorders
- Metabolism and skin diseases
- Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Components of Severity in Alopecia Areata
- The effects of Jawoongo soap on skin improvement
- Methotrexate injection site reactions: Case report and literature review
- Photosensitivity reaction induced by finasteride
- How does covid-19 affect the skin?
- Approach to Nail Pitting in Pediatric and Adolescent Patients: A Dermatology Perspective
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- Mesenchymal Stem Cell-derived Exosomes in the Treatment of Skin and Subcutaneous Tissue Diseases: A Review
- A review of isotretinoin in the treatment of frontal fibrosing alopecia
- Frontal Fibrosing Alopecia: An Observational Single-Center Study of 306 Cases
- A CLINICAL STUDY OF ALOPECIA AREATA AND TO EVALUAT E OF THE EFFICACY OF 0.03% TOPICAL TACROLIMUS IN ITS TREATMENT
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Advances in the human skin microbiota and its roles in cutaneous diseases
- Local heroes or villains: tissue-resident memory T cells in human health and disease